focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM & Total Voting Rights

4 Dec 2019 12:00

RNS Number : 6775V
Frontier IP Group plc
04 December 2019
 

4 December 2019

 

Frontier IP Group plc

("Frontier IP", the "Group" or "the Company")

 

Result of Annual General Meeting and Total Voting Rights

 

Frontier IP Group plc (AIM: FIPP), a specialist in commercialising university intellectual property, announces that, at its annual general meeting held earlier today, all resolutions were duly passed on a show of hands. Resolutions 9 and 10 relate to the Placing, as announced on 6 November 2019.

 

The proxy voting results for the Resolutions are summarised in the table below:

 

 RESOLUTIONS

NO OF VOTES FOR

% OF VOTES CAST (EXCLUDING VOTES WITHELD)

NO OF VOTES AGAINST

% OF VOTES CAST (EXCLUDING VOTES WITHELD)

TOTAL VOTES CAST (EXCLUDING VOTES WITHHELD)

NO OF VOTES WITHHELD

ORDINARY

1) To receive and adopt the financial statements for the year ended 30 June 2019 together with the Directors' report and the auditor's report thereon

20,940,887

100.0%

-

0.00%

20,940,887

-

2) To approve the directors' remuneration report for the year ended 30 June 2019

20,937,490

99.98%

3,397

0.02%

20,940,887

-

3) To re-appoint as a director Mr K Andrew Richmond

20,938,737

99.99%

1,150

0.01%

20,940,887

1,000

4) To re-appoint as a director Mr Campbell Wilson

20,938,737

99.99%

1,150

0.01%

20,940,887

1,000

5) To re-appoint BDO LLP as auditors

20,939,737

99.99%

1,150

0.01%

20,940,887

-

6) To authorise the directors to fix the remuneration of the auditors

20,938,490

99.99%

2,397

0.01%

20,940,887

-

SPECIAL

7) To authorise the directors to allot shares

20,919,737

99.90%

21,150

0.10%

20,940,887

-

8) To disapply the statutory pre-emption rights over equity shares issued for cash subject to certain limits and restrictions

20,915,340

99.88%

23,150

0.12%

20,940,887

2,397

SPECIAL - THE PLACING

9) To authorise the directors to allot the Placing Shares

20,917,340

99.89%

21,150

0.11%

20,940,887

2,397

10) To disapply the statutory pre-emption rights in respect of the issue of the Placing Shares

20,915,340

99.88%

23,150

0.12%

20,940,887

2,397

 

Votes which have been cast at the discretion of the Chairman have been counted as votes for the resolutions. Votes Withheld are not votes in law and do not count in the number of votes counted for or against a resolution.

Total voting rights

Further to the Company's announcement on 6 November 2019, Admission of the Placing Shares is expected to take place at 8:00 a.m. on 5 December 2019.

On Admission, the issued share capital of the Company will consist of 50,431,372 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 50,431,372. From Admission, this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company pursuant to the FCA's Disclosure Guidance and Transparency Rules.

Capitalised terms used but not defined in this announcement shall have the meanings given to such terms in the announcement issued by the Company dated 6 November 2019 unless otherwise defined herein.

 

Enquiries

Frontier IP Group plc

0207 332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

07464 546 025

www.frontierip.co.uk

 

 

Allenby Capital Limited (Nominated Adviser)

0203 328 5656

Nick Athanas / Nicholas Chambers

 

 

N+1 Singer (Broker)

0207 496 3000

Harry Gooden / George Tzimas

 

About Frontier IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKQDPDBDDFBK
Date   Source Headline
28th Jul 20205:22 pmRNSHolding(s) in Company
22nd Jul 202012:50 pmRNSHolding(s) in Company
21st Jul 20209:05 amRNSSecond Price Monitoring Extn
21st Jul 20209:00 amRNSPrice Monitoring Extension
21st Jul 20207:00 amRNSResult of Capital Raising
20th Jul 20204:37 pmRNSPrimaryBid.com Offer
20th Jul 20204:35 pmRNSProposed Capital Raising of a minimum of £2m
20th Jul 20202:00 pmRNSCambridge Raman Imaging completes £250,000 funding
14th Jul 20207:00 amRNSAquaInSilico wins grant to commercialise software
13th Jul 20207:00 amRNSPulsiv demonstrates strong progress
7th Jul 20207:00 amRNSCelerum supports development for PlanSea Solutions
6th Jul 20207:00 amRNSBosch collaboration with Fieldwork
30th Jun 20205:00 pmRNSTotal Voting Rights
23rd Jun 20207:00 amRNSThe Vaccine Group: strong COVID-19 progress
17th Jun 20207:00 amRNSCambridge & FIPP collaborate to tackle gum disease
28th May 20207:10 amRNSPortfolio news: Access to Elute's Patent Reader
28th May 20207:00 amRNSExercise of Options and Total Voting Rights
26th May 20207:00 amRNSPortfolio news – Exscientia raises $60 million
7th May 20207:00 amRNSExscientia and SRI International collaborate
1st May 20207:00 amRNSPortfolio news – Molendotech raises £425,000
15th Apr 20207:00 amRNSPortfolio news – Pulsiv Solar awarded patent
9th Apr 20207:00 amRNSPortfolio news: Alusid launches luxury Block range
6th Apr 202012:01 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSExscientia announces joint initiative re COVID-19
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSElute Intelligence’s AI to back COVID-19 research
26th Mar 20207:00 amRNSPortfolio news: new portfolio company AquaInSilico
25th Mar 20207:00 amRNSUnaudited Half Year Results
19th Mar 20207:00 amRNSFrontier partners University of Lisbon competition
17th Mar 20203:15 pmRNSNotice of interim results
13th Mar 20207:00 amRNSPortfolio news – The Vaccine Group Update
12th Mar 202011:05 amRNSSecond Price Monitoring Extn
12th Mar 202011:00 amRNSPrice Monitoring Extension
19th Feb 202012:37 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSCRIL wins EUR140,000 EU Graphene Flagship funding
12th Feb 20207:00 amRNSPortfolio news - FIPP increases stake in Celerum
31st Jan 20207:00 amRNSPortfolio news - Exscientia
20th Jan 20207:00 amRNSPortfolio news - The Vaccine Group raises £680,000
16th Jan 20203:28 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSFieldwork Robotics secures first equity funding
10th Jan 20207:00 amRNSExscientia enters collaboration with Bayer AG
31st Dec 20191:00 pmRNSTotal Voting Rights
16th Dec 201910:36 amRNSExercise of Options and Issue of Equity
11th Dec 20196:03 pmRNSHolding(s) in Company
9th Dec 20193:25 pmRNSHolding(s) in Company
9th Dec 20193:21 pmRNSHolding(s) in Company
9th Dec 20192:08 pmRNSHolding(s) in Company
9th Dec 20199:46 amRNSHolding(s) in Company
9th Dec 20197:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.